Your session is about to expire
← Back to Search
PST + EUC for Managing Caregiver Stress
N/A
Waitlist Available
Led By Sherry A Beaudreau, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at study completion, up to 41 months or completed participation of all participants, whichever came first
Awards & highlights
Study Summary
This trial will test if a type of therapy can help reduce suicide risk in caregivers of Veterans with dementia, who are at an increased risk for depression and anxiety.
Who is the study for?
This trial is for caregivers over 50 years old who look after a Veteran and have had suicidal thoughts in the past month but are not at immediate risk. They must be able to use the internet for video sessions, not have dementia or severe mental health issues like psychosis, bipolar disorder, or severe OCD. They should also not have recent head injuries, unstable chronic illnesses, or substance abuse problems.Check my eligibility
What is being tested?
The study tests Problem-Solving Therapy delivered via video to reduce suicide risk among caregivers of Veterans with dementia during COVID-19. It aims to see if this approach is practical and well-received by participants.See study design
What are the potential side effects?
Since this intervention involves therapy rather than medication, typical medical side effects are not expected. However, discussing sensitive topics may cause emotional discomfort.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at study completion, up to 41 months or completed participation of all participants, whichever came first
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study completion, up to 41 months or completed participation of all participants, whichever came first
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of treatment
Appropriateness of inclusion/exclusion criteria
Feasibility of recruitment and retention of participants
Secondary outcome measures
Sensitivity of trial outcome measures
Trial Design
1Treatment groups
Experimental Treatment
Group I: Active treatment plus EUCExperimental Treatment1 Intervention
All caregivers are assigned to this condition and receive the treatment plus EUC.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,612 Previous Clinical Trials
3,305,733 Total Patients Enrolled
Sherry A Beaudreau, PhDPrincipal InvestigatorVA Palo Alto Health Care System, Palo Alto, CA
1 Previous Clinical Trials
150 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My senses are not good enough for tests or treatment.I have had a severe head injury or one in the past year.I have not been diagnosed with severe mental health disorders like psychosis, bipolar, or severe OCD.I am not currently taking anti-psychotics for a psychotic disorder.I do not have any severe or unstable chronic illnesses.I do not have any severe or unstable long-term illnesses.I have been diagnosed with dementia.I am under 50 years old.I am currently seeing a therapist for my mental health.I am 50 years old or older.My senses for receiving treatment and assessment are functioning.I haven't had a serious head injury in the past year or ever with unconsciousness over 24 hours.I have been diagnosed with psychosis, bipolar disorder, or severe OCD.I am currently taking medication for psychosis.I can see, hear, and feel well enough to participate in treatments and assessments.
Research Study Groups:
This trial has the following groups:- Group 1: Active treatment plus EUC
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still availability to join this research experiment?
"According to clinicaltrials.gov, the current recruitment phase for this medical trial has concluded; it was first posted on December 1st 2022 and most recently updated on October 19th 2022. However, there are an additional 99 trials recruiting participants at present."
Answered by AI
Who else is applying?
What site did they apply to?
VA Palo Alto Health Care System, Palo Alto, CA
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger